|Articles|June 1, 2008
- The Application Notebook-06-01-2008
- Volume 0
- Issue 0
The Pharma QC Column: OROSIL C18
Author(s)Orochem Technologies Inc.
The QC for the pharmaceutical industry is based on methods developed on a variety of columns. At Orochem, we have attempted to address method development utilizing unique chemistries such as the OROSIL C18 to analyze a wide range of acidic, basic, and neutral compounds. Data is presented on a few representative compounds and unique separation criteria with their associated chromatograms.
The QC for the pharmaceutical industry is based on methods developed on a variety of columns. At Orochem, we have attempted to address method development utilizing unique chemistries such as the OROSIL C18 to analyze a wide range of acidic, basic, and neutral compounds. Data is presented on a few representative compounds and unique separation criteria with their associated chromatograms.
Figure 1
Conclusion
We have successfully developed methods for more than 25 analytes with the Orosil C18 column. The OROSIL C18 chemistry provides a unique platform for the analytes currently targeted by the pharma industry towards major diseased states.
Orochem Technologies Inc,
Eisenhower Ln South, Lombard, IL 60148
Tel: 630-916-0225
Articles in this issue
over 17 years ago
On-site Sample Preparation Using MEPS for Waste Water Analysisover 17 years ago
SELS — Solvent Enhanced Light ScatteringNewsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Navigating Adverse Reactions in GLP-1 Treatment
2
Decoding Sweet Potato Drought Resilience: Metabolomic Evidence from UPLC-MS Profiling
3
Toward Safer Diabetes Devices: GC–MS Detection of Allergens in Sensors, Pumps, and Infusion Sets
4
Shifting GLP-1 Receptor Agonists from Proteins to Small Molecules
5
